Want to join the conversation?
In 3Q16, $CMN saw Endoscopy sales of $91.9MM. Adjusted operating profit increased by over 42% due to strong volumes in all product categories. The company expects investments in international markets to accelerate growth of endoscopy products and support direct sales efforts in major markets such as the UK, Italy, Germany, France and China.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.